Table 3.
Number of patients
|
Annual average cost per patient
|
SD
|
p-value | ||||
---|---|---|---|---|---|---|---|
Oscillococcinum | Control | Oscillococcinum | Control | Oscillococcinum | Control | ||
RRI | |||||||
All patients | 88 | 19 | € 18.27 | € 46.24 | 15.10 | 18.89 | <0.0001 |
Pediatric patients | 88 | 19 | € 18.27 | € 46.24 | 15.10 | 18.89 | <0.0001 |
RTI | |||||||
All patients | 43 | 71 | € 7.07 | € 17.40 | 9.40 | 14.19 | <0.0001 |
Pediatric patients | 2 | 23 | € 5.35 | € 19.53 | 1.93 | 11.65 | 0.0496 |
ARD | |||||||
All patients | 24 | 41 | € 10.87 | € 38.10 | 20.39 | 43.26 | <0.0001 |
Pediatric patients | 2 | 12 | € 4.10 | € 47.94 | 2.64 | 46.11 | 0.0276 |
Asthma | |||||||
All patients | 55 | 47 | € 18.59 | € 44.72 | 16.50 | 27.84 | <0.0001 |
Pediatric patients | 15 | 8 | € 25.72 | € 57.57 | 16.24 | 35.82 | 0.0079 |
COPD | |||||||
All patients | 36 | 31 | € 52.06 | € 121.97 | 40.79 | 120.58 | <0.0001 |
Pediatric patients | 0 | 0 | € 0 | € 0 |
Note: Oscillococcinum® manufactured by Boiron, Messimy, France.
Abbreviations: RRI, recurrent respiratory infection; RTI, respiratory tract infection; ARD, allergic respiratory disease; SD, standard deviation.